Work

B3-06: Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC)

Year: 2007

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/01.jto.0000283158.26734.bc

Authors: Andrea Ardizzoni, Evangelia Razis, Mikhail Lichinitser, Ugur Yilmaz, Alexandru C. Grigorescu, José Luis Morero, Jana Skrickova, Guadalupe Cervantes, Maya Gottfried, Jan Van Meerbeeck

Institutions: University of Parma, Hygeia Hospital, Russian Cancer Research Center NN Blokhin, Dokuz Eylül University, Institutul Oncologic Bucuresti, University Hospital Brno, Institute for Social Security and Services for State Workers, Meir Medical Center, Ghent University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2000832419

FWCI: 0.54

Cites:

Cited by: 4

Related to: 10